Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Relmada Therapeutics Inc (NASDAQ: RLMD)

 
RLMD Technical Analysis
5
As on 9th Jun 2023 RLMD STOCK Price closed @ 2.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 21.48 & Strong Sell for SHORT-TERM with Stoploss of 19.80 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

RLMDSTOCK Price

Open 2.80 Change Price %
High 2.81 1 Day -0.16 -5.69
Low 2.55 1 Week -0.32 -10.77
Close 2.65 1 Month -0.01 -0.38
Volume 141429 1 Year -17.89 -87.10
52 Week High 37.02 | 52 Week Low 2.17
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
RLMD
Daily Charts		 RLMD
Intraday Charts		 Whats New @
Bazaartrend		 RLMD
Free Analysis
 
RLMD Important Levels Intraday
RESISTANCE3.15
RESISTANCE2.99
RESISTANCE2.89
RESISTANCE2.79
SUPPORT2.51
SUPPORT2.41
SUPPORT2.31
SUPPORT2.15
 
RLMD Forecast April 2024
Share
4th UP Forecast13.6
3rd UP Forecast10.09
2nd UP Forecast7.92
1st UP Forecast5.75
1st DOWN Forecast-0.45
2nd DOWN Forecast-2.62
3rd DOWN Forecast-4.79
4th DOWN Forecast-8.3
 
RLMD Weekly Forecast
4th UP Forecast8.60
3rd UP Forecast6.69
2nd UP Forecast5.51
1st UP Forecast4.33
1st DOWN Forecast0.97
2nd DOWN Forecast-0.21
3rd DOWN Forecast-1.39
4th DOWN Forecast-3.30
 
RLMD Forecast2024
4th UP Forecast73.7
3rd UP Forecast50.91
2nd UP Forecast36.83
1st UP Forecast22.74
1st DOWN Forecast-17.44
2nd DOWN Forecast-31.53
3rd DOWN Forecast-45.61
4th DOWN Forecast-68.4
 
 
RLMD Other Details
Segment EQ
Market Capital 408693472.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
RLMD Address
RLMD
 
RLMD Latest News
 
Your Comments and Response on Relmada Therapeutics Inc
 
RLMD Business Profile
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, an oral agent, which is in Phase II clinical trial for the treatment of depression, neuropathic pain, and other potential CNS pathological conditions. The company is also developing LevoCap ER, an abuse resistant, sustained release dosage form of the opioid analgesic levorphanol; BuTab, an oral dosage form of the opioid analgesic buprenorphine; and MepiGel, an orphan drug designated topical formulation of the local anesthetic mepivacaine. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in New York, New York. Address: 880 Third Avenue, New York, NY, United States, 10022
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service